Elsevier

Journal of Psychiatric Research

Volume 99, April 2018, Pages 151-158
Journal of Psychiatric Research

Obesity, dyslipidemia and brain age in first-episode psychosis

https://doi.org/10.1016/j.jpsychires.2018.02.012Get rights and content

Highlights

  • Both overweight/obesity and FEP were associated with advanced brain age.

  • The effects of overweight/obesity on brain age were additive to the effects of FEP.

  • Brain versus chronological age difference was largest in FEP with overweight/obesity.

  • Advanced brain age in FEP and overweight/obesity was not related to treatment with antipsychotics.

Abstract

Introduction

Obesity and dyslipidemia may negatively affect brain health and are frequent medical comorbidities of schizophrenia and related disorders. Despite the high burden of metabolic disorders, little is known about their effects on brain structure in psychosis. We investigated, whether obesity or dyslipidemia contributed to brain alterations in first-episode psychosis (FEP).

Methods

120 participants with FEP, who were undergoing their first psychiatric hospitalization, had <24 months of untreated psychosis and were 18–35 years old and 114 controls within the same age range participated in the study. We acquired 3T brain structural MRI, fasting lipids and body mass index. We used machine learning trained on an independent sample of 504 controls to estimate the individual brain age of study participants and calculated the BrainAGE score by subtracting the chronological from the estimated brain age.

Results

In a multiple regression model, the diagnosis of FEP (B = 1.15, SE B = 0.31, p < 0.001) and obesity/overweight (B = 0.92, SE B = 0.35, p = 0.008) were each additively associated with BrainAGE scores (R2 = 0.22, F(3, 230) = 21.92, p < 0.001). BrainAGE scores were highest in participants with FEP and obesity/overweight (3.83 years, 95%CI = 2.35-5.31) and lowest in normal weight controls (−0.27 years, 95%CI = −1.22-0.69). LDL-cholesterol, HDL-cholesterol or triglycerides were not associated with BrainAGE scores.

Conclusions

Overweight/obesity may be an independent risk factor for diffuse brain alterations manifesting as advanced brain age already early in the course of psychosis. These findings raise the possibility that targeting metabolic health and intervening already at the level of overweight/obesity could slow brain ageing in FEP.

Introduction

Schizophrenia is among the most disabling psychiatric disorders (Whiteford et al., 2013). It is frequently associated with neuroanatomical alterations (Vita et al., 2006, Fornito et al., 2009), which may contribute to impaired functioning (Dazzan et al., 2015). Yet, the origins of brain changes in schizophrenia remain poorly understood and there is no treatment for them. One potential source of neuroimaging abnormalities in psychotic disorders is the comorbidity with medical conditions known to affect the brain.

Almost 1 in 2 participants with schizophrenia are overweight, and at least 2 in 5 suffer from dyslipidemia (Mitchell et al., 2013b). Increased rates of metabolic alterations are found already early in the course of illness. Overweight/obesity, low HDL-cholesterol and hypertryglyceridaemia each affect about 20% of participants with first-episode psychosis (FEP) (Mitchell et al., 2013a). The early onset and lifelong presence of metabolic alterations contribute to poor medical and psychiatric outcomes in schizophrenia (Saha et al., 2007, Brown et al., 2010, Bora et al., 2017) and other psychotic disorders (Bora et al., 2017, Hajek et al., 2016). Among metabolic alterations, obesity and dyslipidemia are the strongest contributors to cognitive impairment and functional decline in psychotic disorders (Bora et al., 2017), which may be related to the negative effects of these comorbidites on the brain.

Neurostructural alterations are frequently reported in participants with obesity (Debette et al., 2010, Tiehuis et al., 2014, Sala et al., 2014, Cherbuin et al., 2015, Masouleh et al., 2016), even in absence of other pathology (Yau et al., 2014, Alosco et al., 2014, Ou et al., 2015). These changes manifest already in adolescence (Mueller et al., 2012, Alosco et al., 2014, Ross et al., 2015, Yokum and Stice, 2017) and tend to be most pronounced in frontal lobes and limbic regions, including insula and hippocampus (Willette and Kapogiannis, 2015). Dyslipidemia may contribute to neurostructural alterations in obesity, with which it often clusters (Friedman et al., 2014, Schwarz et al., 2018). Furthermore, obesity enhances the negative effects of psychiatric morbidity on the brain (Bond et al., 2011, Bond et al., 2014), which may in turn yield adverse psychiatric outcomes (Opel et al., 2015). Interestingly, brain alterations in obesity or dyslipidemia may be preventable or treatable (Mueller et al., 2015, Tuulari et al., 2016, Mansur et al., 2017b) and resemble some of the most replicated neurostructural findings in schizophrenia and related disorders.

Longitudinal studies have shown accelerated age related loss of fronto-limbic volumes, already early in the course of schizophrenia (Paus et al., 2008, Gogtay, 2008, Shaw et al., 2010, Gogtay and Thompson, 2010). Consequently, participants with FEP typically demonstrate smaller volumes of frontal lobes, hippocampus and insula (Ganzola et al., 2014, Torres et al., 2016, Lee et al., 2016, Dietsche et al., 2017). Many of these changes progressively worsen, especially in the first years of illness (van Haren et al., 2007, Andreasen et al., 2011, Vita et al., 2012, Lee et al., 2016). This is likely related to accumulation of certain clinical variables (Zipursky et al., 2013, Zipursky, 2014). Thus, studying the interplay between obesity, dyslipidemia and brain health could help identify preventable risk factors for neuroimaging abnormalities in schizophrenia and related disorders and could provide insight into their pathophysiology and treatment.

Access to large databases of brain scans and advances in neuroimaging analyses involving machine learning, allow us to estimate the biological age of the brain from MRI (Franke et al., 2013, Koutsouleris et al., 2014). The difference between brain age and chronological age captures diffuse, multivariate neurostructural alterations into a single number. This mitigates the problem of multiple comparisons and yields relatively unbiased estimates of effect size (Reddan et al., 2017). Aside from age related changes, this measure is sensitive to brain alterations in schizophrenia (Koutsouleris et al., 2014, Schnack et al., 2016, Nenadic et al., 2017) or obesity (Ronan et al., 2016), which typically show greater brain than chronological age.

Here, we used this novel technology to study the effects of metabolic markers on brain structure in FEP. We expected, that participants with FEP, obesity and possibly dyslipidemia would demonstrate neurostructural alterations, which would make their brains appear older than their chronological age and that the effects of these factors on brain structure would be additive.

Section snippets

Materials and methods

This was a part of the Early Stages of Schizophrenia study (Spaniel et al., 2016). To ensure generalizability, we recruited participants during their first hospitalization in a large general psychiatry hospital (1200 beds), which serves the Prague and part of Central Bohemia regions - catchment area of over 1.5 million subjects. We focused on individuals with FEP, who met the following inclusion criteria: 1) were undergoing their first psychiatric hospitalization, 2) had the ICD-10 diagnosis of

Statistical analyses

Our analytical plan included the following steps: 1) we investigated associations between individual metabolic variables and BrainAGE scores, using correlation coefficients for continuous and two-sample t-tests for categorical variables; 2) we explored the effects of age and sex on BrainAGE scores, to select, which nuisance variables to control for in multivariate analyses; 3) the variables significantly associated with BrainAGE scores in step 1, were entered into multiple linear regression

Results

We recruited 120 participants with FEP and 114 controls, Table 1.

BrainAGE scores were significantly associated with diagnosis of FEP (t(232) = 2.82, p = 0.005), overweight/obesity category (t(232) = 2.74, p = 0.007) and BMI (r(232) = 0.15, p = 0.02, Fig. 1A–C). The association between BrainAGE score and BMI was related to association between BrainAGE score and weight (r(232) = 0.17, p = 0.009), not height (r(232) = 0.10, p = 0.13).

BrainAGE scores were not associated with LDL-cholesterol

Discussion

This study suggests that overweight/obesity, which is frequent in schizophrenia, may contribute to neurostructural changes already early in the course of illness. Specifically, the brains of participants with FEP appeared on average 2.64 years older than their chronological age. Weight and BMI were also significantly positively associated with advanced brain age. Consequently, BrainAGE scores were highest in participants with a combination of FEP and overweight/obesity, where the average

Study concept and design

Hajek, Spaniel, Kolenic.

Acquisition, analysis, or interpretation of data

All authors.

Drafting of the manuscript

Hajek.

Critical revision of the manuscript for important intellectual content

All authors.

Statistical analysis

Hajek, Franke, Alda, Uher, Kolenic, Hlinka.

Obtaining funding

Hajek, Spaniel, Pausova, Alda, Franke.

Administrative, technical, or material support

Franke, Kolenic, Capkova, Matejka, Spaniel.

Study supervision

Hajek, Spaniel.

Conflict of interest disclosures

None of the authors has any conflict of interest to disclose.

Funding/support

Dr. Hajek received funding for this study from Canadian Institute of Health Research (grant #341717), Brain and Behavior Research Foundation (Independent Investigator Award # 23412), the Ministry of Health of the Czech Republic (F.S., grant

References (96)

  • C. Gubert et al.

    Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects

    J. Psychiatr. Res.

    (2013)
  • T. Hajek et al.

    Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders

    Biol. Psychiatr.

    (2015)
  • Y.Y. Hoogendam et al.

    Determinants of cerebellar and cerebral volume in the general elderly population

    Neurobiol. Aging

    (2012)
  • M.J. Kempton et al.

    Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies

    Schizophr. Res.

    (2010)
  • E.C. Leritz et al.

    Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults

    Neuroimage

    (2011)
  • R.B. Mansur et al.

    Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study

    J. Affect. Disord.

    (2017)
  • R.B. Mansur et al.

    Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders

    Eur. Neuropsychopharmacol

    (2017)
  • A. Minichino et al.

    Investigating the link between drug-naive first episode psychoses (FEPs), weight gain abnormalities and brain structural damages: relevance and implications for therapy

    Prog. Neuro-Psychopharmacol. Biol. Psychiatry

    (2017)
  • I. Nenadic et al.

    BrainAGE score indicates accelerated brain aging in schizophrenia, but not bipolar disorder

    Psychiatr. Res.

    (2017)
  • N. Opel et al.

    Obesity and major depression: body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations

    Psychoneuroendocrinology

    (2015)
  • L. Ronan et al.

    Obesity associated with increased brain age from midlife

    Neurobiol. Aging

    (2016)
  • N. Ross et al.

    Obesity, fitness, and brain integrity in adolescence

    Appetite

    (2015)
  • N.F. Schwarz et al.

    Differential associations of metabolic risk factors on cortical thickness in metabolic syndrome

    Neuroimage Clin

    (2018)
  • C. Thomas et al.

    Teaching an adult brain new tricks: a critical review of evidence for training-dependent structural plasticity in humans

    Neuroimage

    (2013)
  • U.S. Torres et al.

    Patterns of regional gray matter loss at different stages of schizophrenia: a multisite, cross-sectional VBM study in first-episode and chronic illness

    Neuroimage Clin

    (2016)
  • A.L. Urback et al.

    Cerebrovascular reactivity measured by functional magnetic resonance imaging during breath-hold challenge: a systematic review

    Neurosci. Biobehav. Rev.

    (2017)
  • A. Vita et al.

    Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies

    Schizophr. Res.

    (2006)
  • L.J. Whalley et al.

    Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people

    Neurosci. Lett.

    (2003)
  • H.A. Whiteford et al.

    Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

    Lancet

    (2013)
  • A.A. Willette et al.

    Does the brain shrink as the waist expands?

    Ageing Res. Rev.

    (2015)
  • E.J. Wolf et al.

    Contributions of polygenic risk for obesity to PTSD-related metabolic syndrome and cortical thickness

    Brain Behav. Immun.

    (2017)
  • M.L. Alosco et al.

    Body mass index and brain structure in healthy children and adolescents

    Int. J. Neurosci.

    (2014)
  • N.C. Andreasen et al.

    Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study

    Am. J. Psychiatr.

    (2013)
  • C. Benedict et al.

    Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly

    Diabetes Care

    (2012)
  • J.F. Bobb et al.

    Cross-sectional and longitudinal association of body mass index and brain volume

    Hum. Brain Mapp.

    (2014)
  • H.B. Boos et al.

    Brain volumes in relatives of patients with schizophrenia: a meta-analysis

    Arch. Gen. Psychiatr.

    (2007)
  • E. Bora et al.

    The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis

    Psychol. Med.

    (2017)
  • S. Brown et al.

    Twenty-five year mortality of a community cohort with schizophrenia

    Br. J. Psychiatry

    (2010)
  • N. Cherbuin et al.

    Being overweight is associated with hippocampal atrophy: the PATH through Life Study

    Int. J. Obes.

    (2015)
  • P. Dazzan et al.

    Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research

    Schizophr. Bull.

    (2015)
  • G. De Backer et al.

    European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of european and other societies on cardiovascular disease prevention in clinical practice

    Eur. Heart J.

    (2003)
  • L. De Peri et al.

    Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies

    Curr. Pharmaceut. Des.

    (2012)
  • S. Debette et al.

    Visceral fat is associated with lower brain volume in healthy middle-aged adults

    Ann. Neurol.

    (2010)
  • B. Dietsche et al.

    Structural brain changes in schizophrenia at different stages of the illness: a selective review of longitudinal magnetic resonance imaging studies

    Aust. N. Z. J. Psychiatr.

    (2017)
  • A. Fornito et al.

    Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder

    Curr. Opin. Psychiatr.

    (2009)
  • K. Franke et al.

    Longitudinal changes in individual BrainAGE in healthy aging, mild cognitive impairment, and Alzheimer's Disease

    GeroPsych: The Journal of Gerontopsychology and Geriatric Psychiatry

    (2012)
  • K. Franke et al.

    Advanced BrainAGE in older adults with type 2 diabetes mellitus

    Front. Aging Neurosci.

    (2013)
  • P. Fusar-Poli et al.

    Diagnostic stability of ICD/DSM first episode psychosis diagnoses: meta-analysis

    Schizophr. Bull.

    (2016)
  • Cited by (64)

    • BrainAGE, brain health, and mental disorders: A systematic review

      2024, Neuroscience and Biobehavioral Reviews
    • Impact of weight loss on brain age: Improved brain health following bariatric surgery

      2022, NeuroImage
      Citation Excerpt :

      However, no significant association was observed with changes in LDL-cholesterol or triglycerides levels. This is consistent with the study from Kolenic et al. that did not find significant associations between delta age and lipid profiles (Kolenic et al., 2018). Our results are also consistent with our previous findings showing that the increase in grey matter and white matter densities after bariatric surgery are correlated with weight loss and improvement of the metabolic/inflammatory profiles (Michaud et al., 2020).

    View all citing articles on Scopus
    1

    These authors contributed equally.

    View full text